Ford HT - Search Results

1

Topical calcipotriol treatment in advanced breast cancer.

Bower M, Colston KW, Stein RC, Hedley A, Gazet JC, Ford HT, Combes RC. Bower M, et al. Among authors: ford ht. Lancet. 1991 Mar 23;337(8743):701-2. doi: 10.1016/0140-6736(91)90280-3. Lancet. 1991. PMID: 1672178

2

Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial.

Stein RC, Bower M, Law M, Bliss JM, Barton C, Gazet JC, Ford HT, Coombes RC. Stein RC, et al. Among authors: ford ht. Eur J Cancer. 1992;28A(12):1963-5. doi: 10.1016/0959-8049(92)90237-v. Eur J Cancer. 1992. PMID: 1419290 Clinical Trial.

3

Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).

Gazet JC, Ford HT, Coombes RC. Gazet JC, et al. Among authors: ford ht. Br J Cancer. 1991 Feb;63(2):279-82. doi: 10.1038/bjc.1991.65. Br J Cancer. 1991. PMID: 1825469 Free PMC article. Clinical Trial.

4

Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A.

Stein RC, Dowsett M, Davenport J, Hedley A, Ford HT, Gazet JC, Coombes RC. Stein RC, et al. Among authors: ford ht. Cancer Res. 1990 Mar 1;50(5):1381-4. Cancer Res. 1990. PMID: 2137367

5

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.

Stein RC, Dowsett M, Hedley A, Gazet JC, Ford HT, Coombes RC. Stein RC, et al. Among authors: ford ht. Br J Cancer. 1990 Oct;62(4):679-83. doi: 10.1038/bjc.1990.356. Br J Cancer. 1990. PMID: 2145964 Free PMC article. Clinical Trial.

6

Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione.

Stein RC, Dowsett M, Hedley A, Davenport J, Gazet JC, Ford HT, Coombes RC. Stein RC, et al. Among authors: ford ht. Cancer Chemother Pharmacol. 1990;26(1):75-8. doi: 10.1007/BF02940300. Cancer Chemother Pharmacol. 1990. PMID: 2322991

7

Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study.

Stein RC, Dowsett M, Cunningham DC, Davenport J, Ford HT, Gazet JC, von Angerer E, Coombes RC. Stein RC, et al. Among authors: ford ht. Br J Cancer. 1990 Mar;61(3):451-3. doi: 10.1038/bjc.1990.99. Br J Cancer. 1990. PMID: 2328214 Free PMC article.

8

Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates.

Coombes RC, Powles TJ, Berger U, Wilson P, McClelland RA, Gazet JC, Trott PA, Ford HT. Coombes RC, et al. Among authors: ford ht. Lancet. 1987 Sep 26;2(8561):701-3. doi: 10.1016/s0140-6736(87)91071-3. Lancet. 1987. PMID: 2888939

9

Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer.

Gazet JC, Markopoulos C, Ford HT, Coombes RC, Bland JM, Dixon RC. Gazet JC, et al. Among authors: ford ht. Lancet. 1988 Mar 26;1(8587):679-81. doi: 10.1016/s0140-6736(88)91478-x. Lancet. 1988. PMID: 2895214 Clinical Trial.

10

Oral gestrinone: a novel antiprogestin with no antitumor activity in endocrine-sensitive breast cancer.

Cunningham D, Gazet JC, Ford HT, Coombes RC. Cunningham D, et al. Among authors: ford ht. Cancer Treat Rep. 1987 Nov;71(11):1091-2. Cancer Treat Rep. 1987. PMID: 3677115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters